Ikarian Capital »

Tarsus Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $34M 1.0M 32.89
2024-06-30 $22M 800k 27.18
2024-03-31 $30M 810k 36.35
2023-12-31 $13M 619k 20.25
2023-09-30 $9.2M 519k 17.77

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Tarsus Pharmaceuticals

BlackRock
BlackRock
Paradigm Biocapital Advisors
Tang Capital Management
Cowen And Company
Jennison Associates
Vanguard Group
Morgan Stanley
Frazier Life Sciences Management
Perceptive Advisors
Assenagon Asset Management
Ikarian Capital
State Street Corporation
ExodusPoint Capital Management
Geode Capital Management

View all funds holding Tarsus Pharmaceuticals